Immunotherapy
News and reporting on cancer immunotherapy.
A Spanish team is hoping it can further validate promising early results using TCR characteristics to predict the success or failure of pre-surgery chemoimmunotherapy.
Early ESMO Data Show Interferon Signature's Ability to Guide Neoadjuvant Melanoma Immunotherapy
In the Phase I DOMINI trial, patients received combinations of BMS' Opdivo, Yervoy, and 4SC's domatinostat based on their tumors' interferon gamma gene expression.
Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy
Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications.
TCR2 Therapeutics' Gavo-Cel Shrinks Tumors Across Multiple Mesothelin-Expressing Solid Cancers
Results presented during the ESMO Congress demonstrated the autologous T-cell therapy's potential benefit in mesothelioma, cholangiocarcinoma, and ovarian cancer.
Gritstone Bio Raises $55M in PIPE Financing
Frazier Life Sciences Public Fund, Redmile Group, and Gilead Sciences contributed funds, which will be used to advance the use of its EDGE platform in vaccine development.